European Medical Journal

Pioneering a New Concept for Neurology and Multiple Sclerosis – Biosimilar Natalizumab: Interview with Two Key Opinion Leaders

Berger has participated in meetings (lectures, advisory boards, consultations) sponsored and compensated by pharmaceutical ...